Author:
Martin Madge,Sansalone Vittorio,Pivonka Peter
Publisher
Springer International Publishing
Reference60 articles.
1. H.G. Ahlborg, O. Johnell, C.H. Turner, G. Rannevik, M.K. Karlsson, Bone loss and bone size after menopause. N. Engl. J. Med. 349(4), 327–334 (2003).
https://doi.org/10.1056/NEJMoa022464
2. Amgen Inc.: Evenity [Prescribing Information]. Tech. rep. (Amgen Inc., Thousand Oaks, California, 2019).
https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/evenity/evenity_pi_hcp_english.ashx
3. M.S.M. Ardawi, H.A. Al-Kadi, A.A. Rouzi, M.H. Qari, Determinants of serum sclerostin in healthy pre- and postmenopausal women. J. Bone Miner. Res. 26(12), 2812–2822 (2011).
https://doi.org/10.1002/jbmr.479
4. D.M. Black, C.J. Rosen, Postmenopausal osteoporosis. N. Engl. J. Med. 374(3), 254–262 (2016).
https://doi.org/10.1056/NEJMcp1513724
.
http://www.nejm.org/doi/10.1056/NEJMcp1513724
5. L.F. Bonewald, M.L. Johnson, Osteocytes, mechanosensing and Wnt signaling. Bone 42(4), 606–615 (2008).
https://doi.org/10.1016/j.bone.2007.12.224